Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM)

In the absence of identified therapeutic targets, chemotherapy is the main systemic treatment option for triple-negative breast cancer (TNBC). The achievement of a pathological complete response (pCR) after neoadjuvant chemotherapy leads to good outcome, whereas patients not achieving a pCR are at h...

Full description

Bibliographic Details
Main Authors: Maria Vittoria Dieci, Lucia Del Mastro, Michela Cinquini, Filippo Montemurro, Laura Biganzoli, Laura Cortesi, Alberto Zambelli, Carmen Criscitiello, Alessia Levaggi, Benedetta Conte, Massimo Calabrese, Alba Fiorentino, Caterina Marchiò, Corrado Tinterri, Veronica Andrea Fittipaldo, Giovanni Pappagallo, Stefania Gori
Format: Article
Language:English
Published: MDPI AG 2019-08-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/11/8/1137